Cargando…

What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?

Phenobarbital is a first-line treatment of various seizure types in newborns. Dosage individualization maximizing the proportion of patients with drug levels in therapeutic range or sufficient treatment response is still challenging. The aim of this review was to summarize the available evidence on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Šíma, Martin, Michaličková, Danica, Slanař, Ondřej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996486/ https://www.ncbi.nlm.nih.gov/pubmed/33668911 http://dx.doi.org/10.3390/pharmaceutics13030301

Ejemplares similares

Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation
por: Šantavý, Petr, et al.
Publicado: (2022)

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses
por: Šíma, Martin, et al.
Publicado: (2021)

Pharmacokinetics and Optimal Dosing of Phenobarbital
por: Shareef, Safiullah, et al.
Publicado: (2018)

Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications
por: Hartinger, Jan Miroslav, et al.
Publicado: (2023)

Dose Optimization and Targeting Strategies of Anti-Infective Agents
por: Šíma, Martin, et al.
Publicado: (2023)

Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients
por: Dvořáčková, Eliška, et al.
Publicado: (2022)

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice
por: Michaličková, Danica, et al.
Publicado: (2020)

Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model
por: Dvořáčková, Eliška, et al.
Publicado: (2023)

Pharmacokinetics of Intravenous and Oral Phenobarbital Sodium in Healthy Goats
por: Yates, Liana M., et al.
Publicado: (2020)

Ganaxolone versus Phenobarbital for Neonatal Seizure Management
por: Miller, Suzanne L., et al.
Publicado: (2022)

Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections
por: Murínová, Irena, et al.
Publicado: (2022)

Physiologically based pharmacokinetic modeling for dose optimization of quinine–phenobarbital coadministration in patients with cerebral malaria
por: Sae‐heng, Teerachat, et al.
Publicado: (2021)

Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs
por: Královičová, Jana, et al.
Publicado: (2022)

Dose-dependent reversal of KCC2 hypofunction and phenobarbital-resistant neonatal seizures by ANA12
por: Carter, B. M., et al.
Publicado: (2018)

Effect of Chronic Administration of Phenobarbital, or Bromide, on Pharmacokinetics of Levetiracetam in Dogs with Epilepsy
por: Muñana, K.R., et al.
Publicado: (2015)

Use of Phenobarbital in Delirium Tremens
por: Fujimoto, Jeffrey, et al.
Publicado: (2017)

Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin
por: Šíma, Martin, et al.
Publicado: (2022)

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
por: Lommerse, Jos, et al.
Publicado: (2019)

Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
por: Lewis, Tamorah, et al.
Publicado: (2018)

Efficacy of Single Administration of High-dose Phenobarbital Suppository as Initial Therapy for Benign Infantile Convulsions with Mild Gastroenteritis
por: IMATAKA, George, et al.
Publicado: (2018)

Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
por: Cleary, Ryan T., et al.
Publicado: (2013)

Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures
por: Maitre, Nathalie L, et al.
Publicado: (2013)

Use of Phenobarbital to Treat Neonatal Abstinence Syndrome From Exposure to Single vs. Multiple Substances
por: Kushnir, Alla, et al.
Publicado: (2022)

Phenobarbital but Not Diazepam Reduces AMPA/kainate Receptor Mediated Currents and Exerts Opposite Actions on Initial Seizures in the Neonatal Rat Hippocampus
por: Nardou, Romain, et al.
Publicado: (2011)

Phenobarbital for Alcohol Withdrawal: Rapid Patient Disposition
por: Richards, John R.
Publicado: (2000)

Opioid Dependent and Pregnant: What Are the Best Options for Mothers and Neonates?
por: Unger, Annemarie, et al.
Publicado: (2012)

Population pharmacokinetics of extended‐release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide
por: Muñana, Karen R., et al.
Publicado: (2018)

Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal Population
por: O’Hara, Kate, et al.
Publicado: (2020)

Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital.
por: Bishayee, A., et al.
Publicado: (1995)

Correction: Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
por: Cleary, Ryan T., et al.
Publicado: (2013)

Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized control trial
por: Nayeri, Fatemeh, et al.
Publicado: (2015)

Complex spectrum of phenobarbital effects in a mouse model of neonatal hypoxia-induced seizures
por: Quinlan, Sean M. M., et al.
Publicado: (2018)

Spectroscopic detection of brain propylene glycol in neonates: Effects of different pharmaceutical formulations of phenobarbital
por: Pouwels, Petra J.W., et al.
Publicado: (2018)

A Comparative Study of Levetiracetam and Phenobarbital for Neonatal Seizures as a First Line Treatment
por: Akeel, Nagwa Elsayed, et al.
Publicado: (2022)

Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives
por: Hartinger, Jan Miroslav, et al.
Publicado: (2022)

High Phenobarbital Clearance During Continuous Renal Replacement Therapy: A Case Report and Pharmacokinetic Analysis
por: Rosenborg, Staffan, et al.
Publicado: (2014)

Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
por: Ľupták, Matej, et al.
Publicado: (2021)

396 What is the Best Predictor for Vancomycin Nephrotoxicity?
por: Hammoud, Kassem, et al.
Publicado: (2014)

Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters
por: Kang, Seok Kyu, et al.
Publicado: (2015)

Phenobarbital and neonatal seizures affect cerebral oxygen metabolism: a near-infrared spectroscopy study
por: Sokoloff, Max D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a8u1fnved3jqqtk4r642pr4uid